Loading…

Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS)

IntroductionDocosahexaenoic acid (DHA), an omega-3 fatty acid, is important for brain development with possible implications in neurodevelopmental outcomes. In the two-arm, randomised, double-blind, placebo-controlled Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia in Very Pret...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open 2022-05, Vol.12 (5), p.e057482-e057482
Main Authors: Guillot, Mireille, Robitaille, Carole-Anne, Turner, Laurence, Pronovost, Etienne, Caouette, Georges, Matte-Gagné, Célia, Olivier, François, Bartholomew, Julie, Massé, Édith, Morin, Alyssa, Mohamed, Ibrahim, Marc, Isabelle
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionDocosahexaenoic acid (DHA), an omega-3 fatty acid, is important for brain development with possible implications in neurodevelopmental outcomes. In the two-arm, randomised, double-blind, placebo-controlled Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia in Very Preterm Infants trial, very preterm infants (
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2021-057482